SUPPLEMENTARY METHODS Figure S1. 9-month continuous NANOG overexpression does not lead to epidermal alterations. Representative hematoxylin and eosin (H&E) staining of CTR and TG mice after 9 month-doxycycline treatment of tail skin and back skin (bars correspond to 50 µm). (D) Relative total Nanog mRNA levels (left) and endogenous Nanog mRNA levels (right) in CTR (n=4) and TG (n=4) back skin; CTR (n=4) and TG (n=3) papillomas; and TG (n=3) SCCs. Each sample (back skin, papilloma or SCC) is from a different mouse at the humane endpoint or at the end of the experiment (30 weeks). mRNA levels were normalized by Gapdh levels. As a positive control, mouse embryonic stem cells (mESCs) were used.
(E) IHC of NANOG and P63 in representative CTR and TG papillomas. P63 was used as a marker of epidermal progenitor cells.
(F) IHC of NANOG in a SCC and lymph node metastasis from the same mouse.
(Bars correspond to 500µm in the low magnification pictures and to 50µm in the high magnification pictures).
(G) mRNA levels in SCC and lymph node metastasis from paraffin embedded tissue sections of the indicated genes.
Bars in graphs correspond to mean ± SD of the indicated number of mice (n). 
